3 Papers
59 Citations
Thomas Razler is an academic researcher from Johnson & Johnson Pharmaceutical Research and Development. The author has contributed to research in topics: Regioselectivity & Intramolecular force. The author has an hindex of 2, co-authored 3 publications. Previous affiliations of Thomas Razler include Johnson & Johnson.
Chat about Author
Papers
Synthesis of pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines via palladium-catalyzed intramolecular arylation
TL;DR: In this paper, a palladium-catalyzed intramolecular arylation of pyrimidine substrates was used to synthesize 4-aryloxy- or 4-anilino-5-iodopyrimidines.
48
Inhibitors of unactivated p38 MAP kinase.
James L. Bullington,Dennis C. Argentieri,Kristin M. Averill,Demetrius Carter,Druie Cavender,Bohumila Fahmy,Xiaodong Fan,Hall Daniel A,Geoffrey R. Heintzelman,Paul F. Jackson,Wai Ping Leung,Xun Li,Ping Ling,Gilbert C. Olini,Thomas Razler,Michael Reuman,Kenneth C. Rupert,Ronald K. Russell,John Siekierka,Scott A. Wadsworth,Russell Wolff,Bangping Xiang,Yue Mei Zhang +22 more
TL;DR: A novel series of pyridinylimidazole-based compounds are developed, which potently inhibit the p38 pathway by binding to unactivated p38 kinase and only weakly inhibiting activated p38 Kinase activity in vitro.
14
Synthesis of Pyrimido[4,5-b]indoles and Benzo[4,5]furo[2,3-d]pyrimidines via Palladium-Catalyzed Intramolecular Arylation.
TL;DR: In this paper, a palladium-catalyzed intramolecular arylation of pyrimidine substrates was used to synthesize 4-aryloxy- or 4-anilino-5-iodopyrimidines.
2